Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Study Identifier
M11-290
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Plain Language Summary
Available Language(s): English, Dutch (Belgium), Japanese, Polish, Slovak, Spanish
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
4 - 17 Years
Protocol Summary
The purpose of the study is to demonstrate the efficacy and safety, and to assess the pharmacokinetics of adalimumab administered subcutaneously (SC) in pediatric subjects with moderate to severe ulcerative colitis (UC).
Study Locations
Location
Status
Location
Childrens Hospital LA /ID# 147452
Los Angeles, California, United States, 90027
Status
Not applicable
Location
Univ California, San Francisco /ID# 120901
San Francisco, California, United States, 94143-2204
Status
Not applicable
Location
Arnold Palmer Hosp Children /ID# 120898
Orlando, Florida, United States, 32806
Status
Not applicable
Location
Emory University Hospital /ID# 121858
Atlanta, Georgia, United States, 30322
Status
Not applicable
Location
Children's Ctr Digestive, US /ID# 121855
Atlanta, Georgia, United States, 30342
Status
Not applicable
Location
University of Chicago /ID# 120904
Chicago, Illinois, United States, 60637-1443
Status
Not applicable
Showing {first} - {last} of {total} Results